Summary
Gastric fluid samples were aspirated 30 and 60 minutes after the ingestion of two 200 mg tablets of cimetidine. The concentration of cimetidine in these samples was measured and their effect on platelet aggregation assessedin vitro. Gastric fluid samples significantly inhibited adrenaline- and ADP-induced platelet aggregationin vitro. In a further series of experiments, cimetidine solutions, at concentrations found in gastric fluid, inhibited platelet aggregation and thromboxane A2 (TXA2) release,in vitro. Ranitidine, another H2-receptor antagonist, was a more potent inhibitor of platelet aggregation than cimetidine. Since ranitidine is also the more potent H2-receptor antagonist which, unlike cimetidine, does not include an imidazole group (which is known to inhibit TXA2 synthesis) in its structure, we conclude that H2 blockade mediates the observed inhibition of aggregation. This platelet anti-aggregatory effect may be relevant to haemostatic mechanisms involved in bleeding peptic ulcers or gastric erosions exposed to high local concentrations of H2-receptor antagonists.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
D. P. Mikhailidis, A. M. Mikhailidis and P. Dandona,Prevention or cure for stress-induced internal bleeding, Br. Med. J.281, 1005–1006 (1980).
D. P. Mikhailidis, A. M. Mikhailidis and P. Dandona,Cimetidine and somatostatin in gastroduodenal haemorrhage, Lanceti, 274–275 (1981).
D. P. Mikhailidis, A. M. Mikhailidis and P. Dandona,Cimetidine and somatostatin in gastroduodenal haemorrhage, Lanceti, 784 (1981).
J. J. Schentag,False positive ‘Hemoccult’ reaction with cimetidine, N. Eng. J. Med.303, 110 (1980).
B. R. D. McDougall and R. Williams,A controlled clinical trial of cimetidine in the recurrence of variceal haemorrhage: implications about the pathogenesis of haemorrhage, Hepatology3, 69–73 (1983).
D. P. Mikhailidis, A. M. Mikhailidis, M. L. Woollard and P. Dandona,Protection of prostacyclin-like activity in human plasma — a non-enzymatic mechanism? Clin. Sci.62, 177–81 (1982).
D. P. Mikhailidis, R. A. Hutton, J. Y. Jeremy and P. Dandona,Cooling decreases the efficiency of prostaglandin inhibitors of platelet aggregation — a factor of possible relevance in cold-induced pathology, Microcirculation2, 413–23 (1983).
D. P. Mikhailidis, J. Y. Jeremy, M. A. Barradas, N. Green and P. Dandona,Effect of ethanol on vascular prostacyclin (prostaglandin I 2 )synthesis, platelet aggregation and platelet thromboxane release, Br. Med. J.287, 1495–1498 (1983).
J. Y. Jeremy, M. A. Barradas, D. P. Mikhailidis and P. Dandona,The effect of tiaprofenic acid and indomethacin on vascular prostacyclin and platelet thromboxane A 2 production, Pharmatherapeutica4, 260–265 (1985).
D. G. Altman, S. M. Gore, M. J. Gardner and S. J. Pocock,Statistical guidelines for contributors to medical journals, Br. Med. J.286, 1489–1493 (1983).
K. Diem, C. Lentner, Eds.Scientific Tables — Documenta Geigy 7th Edition, p. 647 Geigy Pharmaceuticals, Macclesfield (1975).
F. W. Green, M. M. Kaplan, L. E. Curtis and P. H. Levine,Effect of acid and pepsin on blood coagulation and platelet aggregation, Gastroenterology74, 38–43 (1978).
P. Lubke and W. Hermann,Effetti della cimetidina e della ranitidina sull'emocagulabilita plasmatica, Minerva Med.75, 627–631 (1984).
R. Chakrabarti and S. G. Thompson,Cimetidine and fibrinolysis, Lancetii, 962 (1979).
H. Kostering, U. Rotmann, J. Wieding, Ch. Hoffschmidt, B. Osburg and J. Schrader,Influence of cimetidine on platelet function, blood coagulation and fibrinolysis, Thromb Haemostas50, 432 (1983).
A. M. Hoare, G. V. H. Bradby, C. F. Hawkins, J. Y. Kang and P. W. Dykes,Cimetidine in bleeding peptic ulcer, Lancetii, 671–673 (1979).
J. B. Zeldis, L. S. Friedman and K. J. Isselbacher,Ranitidine: a new H 2 -receptor antagonist, N. Engl. J. Med.309, 1368–73 (1983).
R. Gachalyi, K. Tihanyi, A. Vas and A. Kaldor,In vitro effect of cimetidine on ADP-induced platelet aggregation and thromboxane A 2 synthesis in man, Thromb. Res.35, 105–109 (1984).
D. P. Mikhailidis, M. A. Barradas, J. Y. Jeremy and P. Dandona,In vitro effect of cimetidine on platelet aggregation, Thromb. Res.38, 307–308 (1985).
M. A. Horton, R. J. Amos and R. J. Jones,The effect of histamine H 2 receptor antagonists on platelet aggregation in man, Scand J Haematol31, 15–19 (1983).
M. C. Scrutton, Metiamide is not an α2-adrenoceptor antagonist in human platelets. J Pharm Pharmacol32, 438–439 (1980).
G. Allan and K. E. Eakins.Burinamide is a selective inhibitor of thromboxane-A biosynthesis in human platelet microsomes, Prostaglandins15, 659–661 (1978).
D. P. Mikhailidis, M. A. Barradas, J. Christofides, J. Y. Jeremy and P. Dandona.The misuse of cimetidine in patients with cirrhosis, Hepatology4, 573–574 (1984).
Anonymous,Prevention or cure for stress-induced gastrointestinal bleeding, Br. Med. J.281, 631–632 (1980).
Anonymous,Non-ulcer uses of cimetidine, Br. Med. J.283, 89–90 (1981).
A. E. Young,Stopping the haemorrhage from peptic ulcers, Br. Med. J.284, 530–531 (1982).
H. J. Price, J. J. Skillman, L. S. Bushnell, P. C. Long and W. Silen,Antacid versus cimetidine in preventing acute gastrointestinal bleeding, N. Engl. J. Med.302, 426–430 (1980).
Association of the British Pharmaceutical Industry Compendium 1985–86. Datapharm Publications Limited pp. 551–554 London (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mikhailidis, D.P., Christofides, J., Barradas, M.A. et al. The effect of cimetidine on platelet function: a study involving gastric fluid measurements. Agents and Actions 19, 34–41 (1986). https://doi.org/10.1007/BF01977253
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01977253